相关实验视频

Updated: Jul 9, 2025

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Published on: December 13, 2017

0/1h算法的外部验证和0/2h算法的推导,使用新的 point-of-care Hs-cTnI测定

Luca Koechlin¹, Jasper Boeddinghaus², Pedro Lopez-Ayala³

¹Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; Department of Cardiac Surgery, University Hospital Basel, University of Basel, Switzerland; GREAT network.

American heart journal

|December 2, 2023

概括

高灵敏性心脏托罗邦素I点诊断试验有效排除在非ST段升高心肌梗塞 (NSTEMI) 中,使用0/1h和0/2h算法. 这种诊断工具在紧急情况下为早期NSTEMI检测提供了高准确度.

科学领域:

心脏病学心脏病学
生物标记分析生物标记分析
临床诊断临床诊断临床诊断临床诊断

背景情况:

高灵敏性心脏素I (hs-cTnI) 治疗点 (POC) hs-cTnI-PATHFAST测定是一种新的临床工具.
早期和准确诊断心肌梗塞对于患者的治疗结果至关重要.

研究的目的:

为了外部验证hs-cTnI-PATHFAST 0/1h-算法用于早期的非ST段升高心肌梗塞 (NSTEMI) 诊断.
通过hs-cTnI-PATHFAST测定来导出和验证NSTEMI排除和规则的0/2h算法.

主要方法:

多中心诊断研究,涉及患有急性胸部不适的患者.
使用hs-cTnI-PATHFAST对0/1h算法的外部验证和对0/2h算法的导出/验证.
两个独立的心脏病专家对NSTEMI诊断的中央裁决.

主要成果:

0/1h算法显示了NSTEMI排除100%的灵敏度和NPV,在规则中具有高的PPV和特异性.
在验证队列中,0/2h算法成功排除了NSTEMI在52%的患者中,具有100%的灵敏度和NPV.
0/2h算法实现了NSTEMI规则的PPV为81.6%和97.7%的特异性.

结论:

使用0/1h和0/2h算法进行的POC hs-cTnI-PATHFAST测定,可以快速准确地排除和排除NSTEMI.
该试验为排除NSTEMI提供高灵敏度和负预测值,为排除NSTEMI提供高灵敏度和负预测值,为排除NSTEMI提供高积极预测值和特异性.
这种点的护理测试有助于在急诊室设置高效的NSTEMI诊断.

更多相关视频

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...